Erelzi®

ACTIVE PRINCIPLE:
etanercept

INDICATION:
Psoriasic arthritis
Psoriasis
Juvenile rheumatoid arthritis
Rheumatoid Arthritis
Ankylosing spondylitis

DATE:
23/06/2017

STATUS:
Authorized

MORE INFORMATION